Nido Biosciences

Watertown, United States

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

$86.6M raised

May 2023

Series B

Biotechnology Health Care Neuroscience Personal Health Precision Medicine

Top Investors

Bessemer Venture PartnersEli Lilly5AM VenturesAbingworthOUP (Osage University Partners)

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nido Biosciences

How much funding has Nido Biosciences raised?

Nido Biosciences has raised $86.6M in total funding. The most recent round was Series B. The last funding was announced in May 2023.

Who are Nido Biosciences's investors?

Nido Biosciences's investors include Bessemer Venture Partners, Eli Lilly, 5AM Ventures, Abingworth, OUP (Osage University Partners).

Where is Nido Biosciences headquartered?

Nido Biosciences is headquartered in Watertown, United States.

What does Nido Biosciences do?

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

What stage is Nido Biosciences at?

Nido Biosciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 15, 2023.

MLA

"Nido Biosciences — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/nido-biosciences. Accessed June 15, 2026.

APA

VCBacked. (2023). Nido Biosciences — Funding & Investors. Retrieved June 15, 2026, from https://www.vcbacked.co/company/nido-biosciences

Wikipedia (cite web)

{{cite web |title=Nido Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/nido-biosciences |website=VCBacked |access-date=June 15, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 15, 2023.

Similar Companies in Biotechnology